Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2023 Earnings Call Transcript August 3, 2023
Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.45 EPS, expectations were $1.21.
Operator: Hello. Welcome to Vir Biotechnology Second Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session....
